| PS | performance status |
| ME | myalgic encephalomyelitis |
| CFS | chronic fatigue syndrome |
| TMT-A | Trail Making test-A |
| STAT3 | signal transducer and activator of transcription 3 |
| NF-κB | nuclear factor |
| ITC | isothiocyanate |
| AMPKα | AMP-activated protein kinase α |
| NQO1 | NAD(P)H quinone dehydrogenase 1 |
| FOXO1 | Forkhead box protein O1 |
| PPARα | peroxisome proliferator–activated receptor α |
| ALDH2 | aldehyde dehydrogenase |
| ARE | antioxidant response element |
| EC | Endothelial cells |
| mTRPA1 | mouse transient receptor potential ankyrin 1 |
| hTRPA1 | human transient receptor potential ankyrin 1 |
| mTRPV1 | mouse transient receptor potential vanilloid 1 |
| LPS | lipopolysaccharide |
| iNOS | inducible nitric oxide synthase |
| Jak2 | Janus kinase 2 |
| JNK | c-Jun N-terminal kinase |
| CCL11 | C-C Motif Chemokine Ligand 11 |
| CCL25 | C-C Motif Chemokine Ligand 25 |
| IL3 | Interleukin 3 |
| IL1ra12 | Interleukin 1 Receptor Antagonist 12 |
| IL8ra | Interleukin 8 Receptor Alpha |
| TNFRSF23 | Tumor Necrosis Factor Receptor Superfamily Member 23 |
| TNFRSF4 | Tumor Necrosis Factor Receptor Superfamily Member 4 |
| TNF-a | tumor necrosis factor-alpha |